Companies /Healthcare

Satellos Bioscience Inc. Common Stock

NASDAQ: MSLE Biotechnology
$9.32
▼ $0.36 (−3.72%) today
Markets closed · 2:48am ET
Today · % change

Fundamentals

Market Cap
$205.4M
EPS (TTM)
$-2.01
52-Week Range
$5 – $13
Street Target
$26.25

About MSLE

Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company is headquartered in Toronto, Canada.

MSLE Coverage